Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline.

AUTOR(ES)

Lafranconi, W M

RESUMO

Administration of monocrotaline, a pyrrolizidine alkaloid, to male Sprague-Dawley rats for up to three weeks increased dry lung weights by 64% and reduced the specific activity of lung angiotensin-converting enzyme activity by 64%. When the total activity per lung is calculated, however, there is no significant difference between control and monocrotaline-treated animals. The decrease in specific activity is due to increase in total lung protein (52% above control) and not to an actual reduction in the total angiotensin-converting enzyme activity in th lung.

Documentos Relacionados

• Angiotensin-converting enzyme and male fertility
• Serum beta-2-microglobulin and angiotensin-converting enzyme activity in sarcoidosis.
• Angiotensin-Converting Enzyme from Rabbit Pulmonary Particles
• Phosphorus-containing inhibitors of angiotensin-converting enzyme.
• Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.